Press "Enter" to skip to content

Eli Lilly pauses trial of antibody drug touted by Trump as COVID-19 cure

Just a day after Johnson and Johnson temporarily paused its COVID-19 vaccine trial, US pharmaceutical firm Eli Lilly has suspended the government-sponsored Phase 3 trial of its lab-produced antibody treatment in hospitalised patients over safety concerns. 

Leave your comments

%d bloggers like this: